Status:
COMPLETED
Tyrosine Hydroxylase Antibody Levels in Autoimmune Polyglandular Syndrome Type 1 Associated Keratitis
Lead Sponsor:
The Eye Center and The Eye Foundation for Research in Ophthalmology
Conditions:
Autoimmune Polyglandular Syndrome Type I
Autoimmune Keratitis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Tyrosine hydroxylase autoantibodies impair sympathetic innervation leading to keratitis. In this study, the investigators have shown the significant association between severity of keratitis and prese...
Detailed Description
Sixteen consecutive cases diagnosed with APS-1associated keratitis were included in this study. Each patient underwent complete ophthalmologic examination. Blood was obtained from each patient for tes...
Eligibility Criteria
Inclusion
- consecutive patients diagnosed with APS-1associated keratitis
Exclusion
- None
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 6 2014
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04375852
Start Date
January 1 2014
End Date
June 6 2014
Last Update
May 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.